Recently identified genetic markers, called single nucleotide polymorphisms, that are associated with a small but statistically significant increase in the risk of breast cancer do not appear to substantially improve the accuracy of existing models that use clinical factors to predict an individual's risk, according to a new study in the Journal of the National Cancer Institute.